CVRx (CVRX) EBT Margin (2020 - 2026)
CVRx's quarterly EBT Margin came in at 88.83% in Q1 2026, up 2270.0% year-on-year from 3.75% in Q1 2025, and down 19.2% quarter-over-quarter from 74.52% in Q4 2025.
CVRx has reported EBT Margin for 7 years, with the latest figure at 88.83% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 2270.0% year-over-year to 88.83%; the trailing twelve-month figure through Mar 2026 stood at 89.17% (up 831.0% YoY), and the FY2025 full-year result was 94.13%, up 2267.0% from the prior year.
- EBT Margin for Q1 2026 stood at 88.83%, down from 74.52% in the prior quarter.
- The five-year high for EBT Margin was 69.89% in Q4 2024, with the low at 244.48% in Q1 2022.
- Average EBT Margin over 5 years is 127.17%, with a median of 111.52% recorded in 2025.
- Year-over-year, EBT Margin jumped 34787 bps in 2022 and tumbled 6352 bps in 2024.
- Tracing CVRX's EBT Margin over 5 years: stood at 146.43% in 2022, then surged by 45 bps to 80.71% in 2023, then advanced by 13 bps to 69.89% in 2024, then dropped by 7 bps to 74.52% in 2025, then fell by 19 bps to 88.83% in 2026.
- The last three EBT Margin figures came in at 88.83% (Q1 2026), 74.52% (Q4 2025), and 87.63% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | CVRx | 144.43 Mn | 72.13 Mn | 12.88 Mn | -88.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -88.83% |
| Dec 31, 2025 | -74.52% |
| Sep 30, 2025 | -87.63% |
| Jun 30, 2025 | -108.46% |
| Mar 31, 2025 | -111.52% |
| Dec 31, 2024 | -69.89% |
| Sep 30, 2024 | -97.60% |
| Jun 30, 2024 | -118.47% |
| Mar 31, 2024 | -205.65% |
| Dec 31, 2023 | -80.71% |
| Sep 30, 2023 | -85.35% |
| Jun 30, 2023 | -122.28% |
| Mar 31, 2023 | -142.12% |
| Dec 31, 2022 | -146.43% |
| Sep 30, 2022 | -158.39% |
| Jun 30, 2022 | -219.60% |
| Mar 31, 2022 | -244.48% |
| Dec 31, 2021 | -288.27% |
| Sep 30, 2021 | -179.97% |
| Jun 30, 2021 | -567.47% |
| Mar 31, 2021 | -301.05% |
| Dec 31, 2020 | -161.93% |
| Sep 30, 2020 | -321.77% |
| Jun 30, 2020 | -291.60% |